Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
Breaking Down Jazz Pharmaceuticals: 15 Analysts Share Their Views
细分爵士制药：15 位分析师分享他们的观点
Providing a diverse range of perspectives from bullish to bearish, 15 analysts have published ratings on Jazz Pharmaceuticals (NASDAQ:JAZZ) in the last three months.
在过去三个月中，有15位分析师公布了爵士制药（纳斯达克股票代码：JAZZ）的评级，提供了从看涨到看跌的不同视角。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have recently evaluated Jazz Pharmaceuticals and provided 12-month price targets. The average target is $196.6, accompanied by a high estimate of $235.00 and a low estimate of $131.00. A decline of 0.87% from the prior average price target is evident in the current average.
分析师最近对Jazz Pharmicals进行了评估，并提供了12个月的目标股价。平均目标为196.6美元，最高估计值为235.00美元，低估值为131.00美元。目前的平均价格比先前的平均目标股价下降了0.87％。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级：仔细观察
The perception of Jazz Pharmaceuticals by financial...
通过分析师最近...
登录免费看全文
登录/注册